By continuing to use this site, you consent to our use of cookies to personalize your experience and to analyze website traffic. Learn more in our Privacy Policy.

Accept
Privacy Policy

See results of a survey of people who tube feed conducted by Alcresta and the Oley Foundation #

#

Resources & support

RELiZORB (immobilized lipase) cartridge

Welcome to RELiZORB Support Services

Find answers to your questions about RELiZORB, assistance with insurance, financial support, and more

RELiZORB Support Services (RSS) is a support program committed to helping patients who have been prescribed RELiZORB

RELiZORB Support Services (RSS) is a program committed to providing people prescribed RELiZORB with product education, insurance assistance, help with delivery of RELiZORB, and financial support.

RELiZORB Support Services helps patients with:

#
How to use
RELiZORB
#
Insurance
coordination
#
Delivery of
RELiZORB
#
Financial assistance
program

Our mission is to support your RELiZORB journey by helping to remove any obstacles that stand between you and your access to RELiZORB. We are dedicated to offering personalized guidance and ongoing support to ensure you have the resources you need throughout your experience with RELiZORB.

— Cheryl H., RSS Case Manager

Let us help you navigate the complexity of insurance

After your doctor prescribes RELiZORB, you will be asked to complete a RELiZORB Patient Authorization Form.

An RSS Case Manager will reach out to give you an overview of the program so you know what to expect and to confirm your information. They’ll be your point of contact while using RELiZORB and can help with:

  • Working with insurance to help you access RELiZORB
  • Navigating insurance changes
  • Setting up delivery through a specialty pharmacy
  • Coordinating refills
  • Providing further education about RELiZORB

Most commercial and state Medicaid plans cover RELiZORB.

Connect with your dedicated RELiZORB Support Services Case Manager at 1-844-632-9271 or email [email protected].

If you have been prescribed RELiZORB by your doctor, please use these links to provide authorization.

I am signing for myself

I am signing for someone I care for

There was a challenging time in our world where my insurance company was struggling to maintain coverage for [my son]’s RELiZORB, and RELiZORB Support Services was fantastic. They were very supportive. They helped me through every question I had, every challenge I had, they spoke with my insurance company directly. I’m really grateful to have had the support from RELiZORB.

— Pam G., mom of RELiZORB user with cystic fibrosis
Image of RELiZORB support rep on the phone

Explore guides and tools for using RELiZORB

Image of the RELiZORB Overview Brochure

RELiZORB Overview Brochure

Download icon

Get to know even more about RELiZORB and how it helps with your tube feeds in the RELiZORB Overview Brochure.

Download icon
Image of the RELiZORB Getting Started FAQ guide

Getting Started FAQ

Download icon

Get the essential information you need to start using RELiZORB.

Download icon
Image of the list of RELiZORB's compatible feeding formulas and pumps

Compatibility Guide

Download icon

See a list of compatible enteral nutrition types and pumps that have been evaluated for use with RELiZORB.

Download icon
Image of the RELiZORB Refill and Support Contact Card

Refill and Support Contact Card

Download icon

Keep track of your specialty pharmacy and RSS team contact information.

Download icon
Image of the RELiZORB Usage Tracker Calendar

RELiZORB Usage Tracker Calendar

Download icon

Track your progress with a customizable RELiZORB month-at-a-glance calendar.

Download icon
Image of the RELiZORB Patient Brochure

Patient Brochure

Download icon

Download the Patient Brochure for an overview of RELiZORB, including setup instructions.

Download icon
Image of the 'Fat Malabsorption Facts' to Know survey results

Understanding Fat Malabsorption

Download icon

See the results of an Oley survey study, where we asked your peers about their experiences managing fat malabsorption.

Download icon
#

Download the full suite of RELiZORB resources.

Download icon

RELiZORB is indicated for use in pediatric (including neonates and infants) and adult patients to hydrolyze fats during enteral feeding.

Warnings
  • RELiZORB is for use with enteral tube feeding only.
See more
#

RELiZORB is indicated for use in pediatric (including neonates and infants) and adult patients to hydrolyze fats during enteral feeding.

Warnings
  • RELiZORB is for use with enteral tube feeding only.
  • RELiZORB should not be connected to any intravenous (IV) line, setup, or system.
  • Medications should not be administered through the RELiZORB cartridge. Do not add medications to the enteral nutrition or tubing before RELiZORB. The passage of medications through RELiZORB may adversely affect the medications or the ability of RELiZORB to hydrolyze fats.
  • Fibrosing Colonopathy - Fibrosing colonopathy is a rare, serious adverse reaction associated with high-dose use of pancreatic enzyme replacement therapy in the treatment of patients with cystic fibrosis. The underlying mechanism of fibrosing colonopathy remains unknown. Patients with fibrosing colonopathy should be closely monitored because some patients may be at risk of progressing to stricture formation. RELiZORB contains lipase enzyme that is not from a porcine source. The lipase is bound to the beads, and this lipase-bead complex (iLipase) is retained within the RELiZORB cartridge. Continue to follow your physician’s guidance and porcine pancreatic enzyme labeling regarding porcine pancreatic enzyme use when used in conjunction with RELiZORB.
Cautions and Precautions
  • Do not re-use RELiZORB. RELiZORB is a single-use product. Re-use may result in contamination of the product. If re-used, RELiZORB may not effectively hydrolyze fats.
  • Do not break, alter, or place excess pressure on any part of RELiZORB. Any compromise of the structural integrity of RELiZORB may lead to improper connection to enteral feeding supplies, leakage or risk of contamination.
  • Do not use RELiZORB after the date marked on the pouch.
  • Enteral nutrition administered through RELiZORB is for immediate consumption through an enteral feeding tube. RELiZORB should not be used to process enteral nutrition for later use. This has not been tested and may result in safety issues.
  • RELiZORB is designed for use with enteral feeding pump systems with low flow/no flow alarms and enteral syringes for manual bolus by syringe (push or gravity). A detailed listing of enteral nutrition, pumps, and enteral feeding supplies compatible with RELiZORB can be found at www.relizorb.com/compatibility.
  • Patients less than 1 year old may be particularly vulnerable to unplanned interruptions of feeding.
  • Do not use blenderized formulas with RELiZORB. A detailed listing of enteral nutrition compatible with RELiZORB can be found at www.relizorb.com/compatibility.
  • Powdered formulas should be mixed periodically during feedings.
  • Do not use excessive force on the plunger when using RELiZORB with bolus syringe feeding method.
  • Do not rush bolus feeds. Follow guidance from your healthcare professional on how long it should take you to complete your tube feeding. Ensure all inlet and outlet connectors on RELiZORB and enteral feeding supplies are clean and dry prior to making connections.
  • In order to ensure product performance, store RELiZORB in its pouch either refrigerated or at room temperature (2°C to 27°C; 36°F to 80°F).
  • RELiZORB is indicated for use with enteral feeding only; patients should follow physician’s guidance for pancreatic enzyme replacement therapy (PERT) use for meals and snacks. Patients and patient caregivers should follow physician’s guidance regarding the need for pancreatic enzyme replacement therapy (PERT) during enteral feeding.

Review full product information for RELiZORB in the Instructions for Use.